Patients who underwent chemotherapy for non-Hodgkin lymphoma and esophageal, prostate and cervical cancers faced an increased risk of developing acute myeloid leukemia, according to a new study. However, treatment was associated with lower AML risk in patients who had ovarian cancer, myeloma, and possibly lung cancer, researchers said. The findings appear in the journal Blood.